While Ozempic was not developed as a treatment for alcohol use disorder, the growing body of research in this area has attracted significant attention from scientists and healthcare professionals alike
Most people who start semaglutide experience some degree of nausea, fatigue, or appetite suppression in the first 12 weeks, but research shows these effects typically fade significantly by week 6
If you struggle with moderate appetite control rather than severe hyperphagia, or if you're early in your weight management journey, oral formulations may produce satisfactory results
Potential weight regain if the gaps are long as your appetite may increase
This shift may influence not only adherence but also long-term outcomes for patients at earlier stages of disease
In studies published by Novo Nordisk, the manufacturer of Ozempic, people who took the 2-milligram (mg) dose experienced an average of 14 pounds lost over 10 months of treatment